Netherlands· NL-b0a9f0679487
Humaan hepatitis B-immunoglobuline Eureco-Pharma 180 IE/ml oplossing voor injectie
A hepatitis b immunoglobulin product containing humaan hepatitis b immunoglobuline, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HUMAAN HEPATITIS B IMMUNOGLOBULINE
- Manufacturer
- Eureco-Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id131427//129963
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J06BB04
Hepatitis b immunoglobulin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cd30ee6-e6c9-4740-b0ec-6ddf8251651f GET /v1/drugs/5cd30ee6-e6c9-4740-b0ec-6ddf8251651f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129963_smpc.pdf",
"strength": null,
"atc_label": "Hepatitis B Immunoglobulin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131427",
"excipients": [
"GLYCINE (E 640)",
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE"
],
"substances": [
"HUMAAN HEPATITIS B IMMUNOGLOBULINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131427.pdf",
"authorised_at": "2024/03/12",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "131427//129963",
"additional_monitoring": "N"
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.